amyotrophic-lateral-sclerosis

Documents about amyotrophic-lateral-sclerosis

• Beyond outcomes: patients’ lived experience of exoskeleton-assisted gait training in amyotrophic lateral sclerosis#231528HAL (France)
• Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis#869114ClinicalTrials.gov
• High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis#911630ClinicalTrials.gov
• Current potential biomarkers for Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: review of literature#4659Europe PMC
• Very low-amplitude muscle activity increases probability of motor evoked potentials in healthy individuals and in amyotrophic lateral sclerosis#642345Europe PMC
• Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS)#858200ClinicalTrials.gov
• Brain Folding Trajectories in Amyotrophic Lateral Sclerosis#322675IRIS
• Medical Philately: Lou Gehrig#362619The ESRF Research Journal for Undergraduate Medical Students
• Neuropsychological Sub-Phenotypes in Amyotrophic Lateral Sclerosis.#427640NCBI PubMed Central
• MicroRNA and Nrf2 pathway manipulation in human astrocytes: towards a therapeutic approach for Amyotrophic Lateral Sclerosis (ALS)#447191University of Nottingham Repository
• Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)#843573ClinicalTrials.gov
• MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)#994368ClinicalTrials.gov
• Individualized Functional Imaging-Guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Postural Gait Disorders in Patients with Amyotrophic Lateral Sclerosis (ALS): a Randomized, Crossover, Controlled, Double-Blind Clinical Study#854100ClinicalTrials.gov
• Digital Assessment of Speech and Fine Motor Control in ALS#875109ClinicalTrials.gov
• Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis#878071ClinicalTrials.gov
• Alleviating Persistent Dyspnea in Amyotrophic Lateral Sclerosis Patients Treated With Non-Invasive Ventilation Through Immersive Virtual Reality#967768ClinicalTrials.gov
• From Mutation to Manifestation: Penetrance in Amyotrophic Lateral Sclerosis#384785HAL (France)
• Assessing Perceptual Effects of Interactive Tasks#917896ClinicalTrials.gov
• TDP43 aggregates: the ‘Schrödinger’s cat’ in amyotrophic lateral sclerosis#384801HAL (France)
• Circulating protein profiling identifies prognostic biomarkers in amyotrophic lateral Sclerosis#474716bioRxiv / medRxiv
• Developing a Discrimination Model to Diagnose ALS#803234ClinicalTrials.gov
• ALS Testing Through Home-based Outcome Measures#811716ClinicalTrials.gov
• Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation#852018ClinicalTrials.gov
• A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation#882112ClinicalTrials.gov
• Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS#867150ClinicalTrials.gov
• Exploring the interplay between quantitative muscle strength, functional performance, and patient-reported outcomes in amyotrophic lateral sclerosis: a cross-sectional pilot study#231529HAL (France)
• Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis#873600ClinicalTrials.gov
• Biological Treatment of Amyotrophic Lateral Sclerosis#982159ClinicalTrials.gov
• Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients#1032567ClinicalTrials.gov
• Neurocritical progression in amyotrophic lateral sclerosis: pathological relevance and validation.#182699NCBI PubMed Central
• Exploring amyotrophic lateral sclerosis through the visual system: A systematic review#384822HAL (France)
• A proteomic signature for prognostic stratification in amyotrophic lateral sclerosis#471395bioRxiv / medRxiv
• Protein Biomarkers in Risk and Prognosis of Amyotrophic Lateral Sclerosis.#662767NCBI PubMed Central
• Appetite and Related Factors in Patients With ALS#811808ClinicalTrials.gov
• ALS Reversals - Lunasin Regimen#812746ClinicalTrials.gov
• Open-label Clinical Trial of Lacosamide in ALS#885899ClinicalTrials.gov
• Talampanel for Amyotrophic Lateral Sclerosis (ALS)#914701ClinicalTrials.gov
• TMEM106B Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis#476157IRIS
• Safety and efficacy of Atalante exoskeleton-assisted gait training in amyotrophic lateral sclerosis#326241HAL (France)
• Comparative Effect of Different Treatments with a Bacterial Polyketide in a Mouse Model of ALS (Amyotrophic Lateral Sclerosis)#983905HAL (France)
• Screening and Natural History: Primary Lateral Sclerosis and Related Disorders#869330ClinicalTrials.gov
• Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project#883401ClinicalTrials.gov
• Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)#995492ClinicalTrials.gov
• Correlations of clinical and cognitive characteristics with neuroimaging in patients with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS)#462341RosDok
• Unraveling temporal dynamics of the post-mortem transcriptome in amyotrophic lateral sclerosis#10221bioRxiv / medRxiv
• Applications of electromyography in Amyotrophic Lateral Sclerosis: A systematic review.#305079NCBI PubMed Central
• Inflammatory mediators, lipoproteins and apolipoproteins in early diagnosis of amyotrophic lateral sclerosis#384810HAL (France)
• Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Amyotrophic Lateral Sclerosis#384819HAL (France)
• Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS#893260ClinicalTrials.gov
• 42 U.S.C. § 280g-7 — Amyotrophic lateral sclerosis registry#595246US Code (LII)